YN, W., & LS, W. (2026). Noninvasive salivary biomarkers (PTX3, calprotectin, and IL-8) for early-onset neonatal pneumonia: Case-control differences and exploratory discrimination. Frontiers in pediatrics, 14, 1747967. https://doi.org/10.3389/fped.2026.1747967
Chicago Style (17th ed.) CitationYN, Wang, and Wang LS. "Noninvasive Salivary Biomarkers (PTX3, Calprotectin, and IL-8) for Early-onset Neonatal Pneumonia: Case-control Differences and Exploratory Discrimination." Frontiers in Pediatrics 14 (2026): 1747967. https://doi.org/10.3389/fped.2026.1747967.
MLA (9th ed.) CitationYN, Wang, and Wang LS. "Noninvasive Salivary Biomarkers (PTX3, Calprotectin, and IL-8) for Early-onset Neonatal Pneumonia: Case-control Differences and Exploratory Discrimination." Frontiers in Pediatrics, vol. 14, 2026, p. 1747967, https://doi.org/10.3389/fped.2026.1747967.